首页 | 本学科首页   官方微博 | 高级检索  
检索        

环孢霉毒A逆转急性髓系白血病多药耐药一例
引用本文:赵春亭,卞寿庚,杨纯正,薛艳萍,刘瑞林,何一心,奕凤君,刘炳仁.环孢霉毒A逆转急性髓系白血病多药耐药一例[J].中华血液学杂志,1995(7).
作者姓名:赵春亭  卞寿庚  杨纯正  薛艳萍  刘瑞林  何一心  奕凤君  刘炳仁
作者单位:中国医学科学院血液学研究所血液病医院
基金项目:国家八五攻关项目基金、卫生部科学基金
摘    要:报道一例急性髓系白血病(M_(4b)患者,经HAD方案全量化疗两疗程无效,实验室检查示mdrlmRNA(+),p170阳性率31%,多药耐药细胞群占41.76%,证实为多药耐药。第3疗程用环孢霉素A(CsA,4mg/kg,每日两次,第1~3天;2.5mg/kg,每日两次,第4~5天)加类似剂量的HAD方案化疗,取得完全缓解,同时mdrlmRNA和p170转阴,耐药细胞群消失。

关 键 词:多药耐药,环孢霉素A,白血病,髓细胞性,急性

REVERSAL OF MULTIDRUG RESISTANCE BYCYCLOSPORINE A IN A PATIENT WITH ACUTEMYELOID LEUKEMIA
Zhao Chunting, Bzan Shougeng, Yang Chunzheng, etal..REVERSAL OF MULTIDRUG RESISTANCE BYCYCLOSPORINE A IN A PATIENT WITH ACUTEMYELOID LEUKEMIA[J].Chinese Journal of Hematology,1995(7).
Authors:Zhao Chunting  Bzan Shougeng  Yang Chunzheng  etal
Abstract:patient with acute myeloid leukemia M_(4b) showedno response to two courses of HAD regimenchemotherapy . Laboratory studies showed that mdr 1mRNA was positive , and p-170 positive cells and mul-tidrug resistance (MDR) cells were 31% and 41. 76%respectively in bone marrow . The patient was con-firmed to be MDR. Cyclosporine A (4mg/kg twice dai-ly for 3 days , then 2. smg/kg twice daily for 2 days) inaddition to the same HAD regimen was given in thethird course in order to reverse the MDR . The patientobtained CR after this course of therapy with both mdr1 mRNA and p-170 turning to negative and the disap-pearance of MDR cells.
Keywords:S Multidrug resistance CyclosporineA Acute mveloid leukemia
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号